Lymphoseek Receives FDA Approval For Diagnosis of HNSCC
The FDA has approved the diagnostic agent technetium 99m tilmanocept for the detection of the spread of head and neck cancers.
Sophisticated Chest Scans in Children: Increased Risk of Heart Disease
Cutting edge technology used to image young children with heart disease increases their risk of cancer.
HHS Fights Back to Keep Expanded 340B Drug Discounts
The drug industry scored a victory last month against the Obama administration's plans to give hospitals millions of dollars in discounts through the 340B program on orphan drugs. But HHS is sticking to its position that the Patient Protection and Affordable Care Act promises breaks on the expensive drugs when they're used for non-orphan indications.
Low Cholesterol Reduces Survival in Kidney Cancer
New research suggests that a reduction in blood cholesterol might actually prove harmful in kidney cancer patients.
EHR Incentive Cash Climbs to $24B
Some 59 percent have received meaningful use Stage 1 incentives.
How Hospital Palliative Care Programs Drive Value
Americans live in one of the most medically advanced societies in human history. But sometimes, there is no cure for what ails us.
New Hope for Healthcare Costs: Cash Pricing
Negotiating cash payments with medical providers outside the managed-care realm can save a bundle.
Ventana and MedImmune to Develop a PD-L1 Assay To Aid Patient Enrollment in Immunotherapy Trials
Ventana Medical Systems, Inc. and MedImmune today announced they are jointly developing a PD-L1 (SP263) immunohistochemistry assay to enroll patients in clinical trials for MedImmune's MEDI4736 anti-PD-L1 therapy for non-small cell lung carcinoma. This includes the recently commenced MEDI4736 ATLANTIC trial that will enroll only patients who express PD-L1 as determined by the VENTANA assay.
The Promise of Merck's Pembrolizumab in PD-L1-expressing NSCLC
Pembrolizumab was safe and effective in patients with locally advanced or metastatic non–small cell lung cancer that strongly expressed PD-L1, according to study results presented at the ASCO Annual Meeting.
U.S. House Votes to Ensure Speedier Care for Vets
The U.S. House of Representatives passed legislation that makes it easier for patients to receive VA-paid treatment from their local doctors as a way to combat the longer waits for care at Veterans Affairs facilities.
Federal Views Diverge on Proper Use of Painkillers
The recent conversation regarding the abuse of prescription drugs that provide pain relief has some federal government officials calling this epidemic a "growing national crisis". While prescriptions such as Vicodin, OxyContin and other opioid drugs help patients with chronic pain, the White House is asking doctors to curtail their use of prescription opioids.
Michigan To Reward Medicaid Enrollees Who Take ‘Personal Responsibility’
After an exceedingly high Medicaid enrollment this spring, Michigan became the second state to offer incentives and rewards for participants who agree to do health risk assessments with their physicians once a year as well as work to take the proper steps that improve their overall health.
Improved Detection of Metastasized Prostate Cancer with a New Tracer
A study conducted at the Johns Hopkins University demonstrates improved detection of prostate cancer metastasis following the injection of 18F-DCFBC, which binds PSMA.
CYRAMZA Meets Secondary Endpoints in Phase 3 REACH Trial for HCC
CYRAMZA™ (ramucirumab)did not meet its primary endpoint; overall survival favored the CYRAMZA arm but was not statistically significant, in patients with hepatocellular carcinoma, but meaningful improvements in key secondary endpoints of progression-free survival, overall response rate and time to progression were observed.
Herceptin Can Lead to Heart Problems
Nearly 10% of women treated with herceptin were found to be susceptible to heart risks, which reversed once treatment was halted.
Study Puts A Price Tag On Autism
Autism exacts a heavy toll on families across the country, but what is the financial cost of the disorder?
Sebelius Hands Reins to Successor
Kathleen Sebelius handed leadership of the Health and Human Services Department to her successor on Monday and wished new Secretary Sylvia Matthews Burwell the best of luck.
Study Identifies Substantial Variability in the Cost of Prostate Cancer Surgery
Patients who want to compare prices for prostate-cancer surgery may find it rough going: a study has found a 13-fold difference in prices quoted by 100 hospitals across the United States. Moreover, most provided little more than broad estimates, and only three gave a hard copy of the charges.
Rosetta Genomics and Moffitt to Develop microRNA-Based Diagnostic
The agreement will help develop Rosetta's thyroid neoplasia assay.
Clinical Pathways, ACOs, COAs: Introducing 'Value' in Cancer Care
The continued advances in cancer treatment are improving patient survival, but the healthcare industry is bursting at its seams.
Taiho's RECOURSE Trial Meets Primary Endpoint for mCRC in Phase 3
Taiho Pharmaceutical Co., parent company of Taiho Oncology, announced recently that its combination drug for refractory metastatic colorectal cancer met its primary endpoint in a phase 3 global RECOURSE trial.
Coast-to-Coast Health Care Woe: Cost
From coast to coast, people say that their health coverage and care are too expensive.
Some States See in the Health Law a Chance to Pursue Unique Solutions
The federal health-care law was intended to create a uniform standard of health coverage across the U.S. But the law also is creating opportunities for states to pursue their own solutions.
Cleveland Clinic CEO Cosgrove Says No to VA Post
Cleveland Clinic CEO Dr. Toby Cosgrove will not take over the scandal-ridden Veterans Affairs Department and will remain in his current job.